Levothyroxine treatment for persistent cognitive symptoms in major depression

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Revista de Psiquiatría y Salud Mental (English Edition)

• Publication date

  2019-08-20

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.RPSMEN.2019.02.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychoneuroimmunology of mental disorders.

  2017cited by this paper
• Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders

  2015cited by this paper
• Subclinical Hypothyroidism and Cognitive Impairment: Systematic Review and Meta-Analysis.

  2015cited by this paper
• Pharmacological approaches to the challenge of treatment-resistant depression

  2015cited by this paper
• Thyroid disease and cognition.

  2014cited by this paper
• Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study

  2009cited by this paper
• Guía clínica del diagnóstico y tratamiento de la disfunción tiroidea subclínica

  2007cited by this paper
• Minimizing the cognitive effects of lithium therapy and electroconvulsive therapy using thyroid hormone.

  2000cited by this paper
• Treatment of Refractory Depression with High-Dose Thyroxine

  1998cited by this paper
• Clinical and Subclinical Hypothyroidism in Patients with Chronic and Treatment-Resistant Depression

  1996cited by this paper
• E-mail Karger@karger.com Guidelines 2013 Eta Guideline: Management of Subclinical Hypothyroidism

  year unknowncited by this paper

• No citing papers are available for this paper.